期刊文献+

肿瘤患者化疗辅助用药分析 被引量:3

Analysis of adjuvant drugs for chemotherapy in tumor patients
下载PDF
导出
摘要 目的了解某院化疗辅助药物应用现状,促进临床合理用药。方法在2017年7月1日~2018年6月30日期间,临床药师从某院病案室抽取相关科室化疗患者的出院病历。每月抽取病历:肿瘤科10份、放疗科10份、普外科5份、胸外科2份、妇科2份、呼吸内科5份,总计408份。进行化疗辅助药物的统计分析。结果临床药师点评化疗患者住院病历408份,各类化疗辅助药物的使用率排名依次为:止吐药、扶正祛邪类中成药、骨髓功能恢复药、保肝药、抗过敏药、心功能保护药。化疗辅助药物应用合理的病历有345份,应用不合理的病历有63份。化疗辅助药物应用不合理主要表现在用药时机不当、注射剂溶媒选用不当、药物用法用量不当、联合用药不当等方面。结论该院临床应用化疗辅助药物基本规范。该院临床医师重视化疗药物所致的不良反应。 Objective Investigating the application of adjuvant drugs in cancer chemotherapy in a hospital to promote rational drug use in clinic.Methods During the period from July 1,2017 to June 30,2018,medical records of discharged patients undergoing chemotherapy in related departments were sampled randomly from the medical record room of a hospital for the statistical analysis of adjuvant drugs for chemotherapy.10 cases in oncology,10 cases in radiotherapy, 5 cases in general surgery,2 cases in thoracic surgery,2 cases in gynecology and 5 cases in respiratory medicine were chosen randomly every month. The total number of medical records was 408.Results 408 inpatient medical records of chemotherapy patients were reviewed.The usage rate of adjuvant drugs in chemotherapy was ranked as antiemetic drugs,Chinese patent drugs for strengthening the body and eliminating pathogens,bone marrow function restoring drugs,hepatoprotective drugs,anti-allergic drugs and cardioprotective drugs.345 cases of use of adjuvant drugs in chemotherapy were rationa,and 63 cases were irrational.The irrational use of adjuvant drugs for chemotherapy is mainly manifested in unreasonable usage and dosage,inappropriate medication time, improper selection of solvent for injection,improper combination of drugs and so on.Conclusion The clinical application of adjuvant drugs in chemotherapy in this hospital was basically in line with standard.Clinical doctors in this hospital attached importance to adverse reactions caused by chemotherapeutic drugs.
作者 刘国强 唐毅恒 LIU Guo-qiang;TANG Yi-heng(Yizheng Hospital,Drum Tower Hospital Group of Nanjing,Jiangsu Yangzhou,211900,China)
出处 《中国处方药》 2019年第5期52-53,共2页 Journal of China Prescription Drug
关键词 化疗 辅助药物 药物不良反应 合理用药 Chemotherapy Adjuvant drug in chemotherapy Adverse drug reaction Rational drug use
  • 相关文献

参考文献2

二级参考文献50

  • 1杨新杰,张树才.雷莫司琼预防肺癌顺铂化疗所致恶心呕吐效果的随机对照临床研究[J].中国肺癌杂志,2005,8(4):322-325. 被引量:13
  • 2陈映霞,秦叔逵,程颖,陈振东,李进,张清媛,潘良熹.盐酸帕洛诺司琼预防化疗性恶心呕吐的多中心双盲随机对照临床研究[J].临床肿瘤学杂志,2007,12(3):161-165. 被引量:48
  • 3Cvetkovi'c RS,Scott LJ.Dexrazoxane:a review of its use for cardioprotection during anthracycline chemotherapy[J].Drugs,2005,65(7):1005-1024.
  • 4Barry E,Alvarez JA,Scully RE,et al.Anthracycline-induced cardiotoxicity:course,pathophysiology,prevention and management[J].Expert Opin Pharmacother,2007,8 (8):1039-1058.
  • 5Lipshultz SE,Lipsitz SR,Sallan SE,et al.Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia[J].J Clin Oncol,2005,23(12):2629-2636.
  • 6Lipshultz SE,Colan SD,Gelber RD,et al.Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood[J].N EnglJ Med,1991,324(12):808-815.
  • 7Von Hoff DD,Layard MW,Basa P,et al.Risk factors for doxorubicin-induced congestive heart failure[J].Ann Intern Med,1979,91(5):710-717.
  • 8Swain SM,Whaley FS,Ewer MS,et al.Congestive heart failure in patients treated with doxorubicin:a retrospective analysis of three trials[J].Cancer,2003,97 (11):2869-2879.
  • 9Keefe DL.Anthracycline-induced cardiomyopathy[J].Semin Oncol,2001,28(4 Suppl 12):2-7.
  • 10Ganame J,Claus P,Uyttebroeck A,et al.Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients[J].J Am Soc Echocardiogr,2007,20 (12):1351-1358.

共引文献584

同被引文献21

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部